EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells

Maryam J Tavaf, Azita Soltanmohammadi, Simin Zargarani, Esmaeil Yazdanpanah, Bizhan Sadighimoghaddam, Bahman Yousefi, Hamid R Sameni, Dariush Haghmorad iD

Immunity, Inflammation and Disease · 2023-01 · 11 (1)

DOI: 10.1002/iid3.766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 13.01.2023. Verfasst von Maryam J Tavaf und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. Hauptthemen laut MEDLINE: Berberine, Encephalomyelitis, Autoimmune, Experimental, T-Lymphocytes, Regulatory, Th2 Cells. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Among the most frequent demyelinating autoimmune disorders of the central nervous system (CNS) is multiple sclerosis. Experimental autoimmune encephalomyelitis (EAE) is used as an animal model of multiple sclerosis. Berberine is an alkaloid found in some medicinal plants with anti‐inflammatory effects.

Methods

C57BL/6 female mice were used and divided into three groups: (1) The control group received PBS, (2) the low‐dose treatment group received 10 mg/kg of berberine, and (3) The high‐dose treatment group received 30 mg/kg of berberine. Myelin Oligodendrocyte Glycoprotein and complete Freund's adjuvant were subcutaneously administered to induce EAE. Mice were given intraperitoneal injections of pertussis toxin on the day of immunization and 2 days later. Histological studies showed low lymphocyte infiltration and demyelination of CNS in the treated groups.

Results

The clinical scores of the treatment group with low‐dose berberine (T1: 2 ± 0.13) and high‐dose berberine (T2: 1.5 ± 0.14) were significantly ( p < .001) lower than the control group (CTRL: 4.5 ± 0.13). Treatment groups decreased pro‐inflammatory cytokines (IFN‐γ, TNF‐α, interleukin [IL]‐17) ( p < .001) as well as increased anti‐inflammatory cytokine expression (IL‐4, IL‐10, IL‐27, IL‐33, IL‐35, TGF‐β) ( p < .01) when compared to the CTRL group. Treatment groups with berberine reduced expression of the Th1 and Th17 cytokines and transcription factors ( p < .001) and increased expression of transcription factors and Th2 and Treg cytokines ( p < .01) in contrast to CTRL group.

Conclusion

Berberine appears to have a protective effect on disease development and alleviating disease status in EAE, which appears to be due to the cell expansion and function of Treg and Th2 cells in addition to berberine's anti‐inflammatory properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineEncephalomyelitis, Autoimmune, ExperimentalT-Lymphocytes, RegulatoryTh2 CellsAnimalsMiceAnti-Inflammatory AgentsCytokinesMice, Inbred C57BLMultiple SclerosisNeuroinflammatory DiseasesTranscription Factors

Stichwörter der Autor:innen

Berberineexperimental autoimmune encephalomyelitismultiple sclerosismyelin oligodendrocyte glycoprotein

Substanzen

Anti-Inflammatory AgentsBerberineCytokinesTranscription Factors

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Immunology and Allergy, Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nervous System Stem Cells Research Center and Department of Tissue Engineering and Applied Cellular Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
  • Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.

ORCID-Profile: Dariush Haghmorad

Zitieren

APA

Tavaf, M. J., Soltanmohammadi, A., Zargarani, S., Yazdanpanah, E., Sadighimoghaddam, B., Yousefi, B., Sameni, H. R., & Haghmorad, D. (2023). Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells. Immunity, Inflammation and Disease, 11(1). https://doi.org/10.1002/iid3.766

Vancouver

Tavaf MJ, Soltanmohammadi A, Zargarani S, Yazdanpanah E, Sadighimoghaddam B, Yousefi B, et al. Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells. Immunity, Inflammation and Disease. 2023;11(1). doi:10.1002/iid3.766

BibTeX
@article{Tavaf2023,
  author = {Tavaf, Maryam J and Soltanmohammadi, Azita and Zargarani, Simin and Yazdanpanah, Esmaeil and Sadighimoghaddam, Bizhan and Yousefi, Bahman and Sameni, Hamid R and Haghmorad, Dariush},
  title = {Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  volume = {11},
  number = {1},
  doi = {10.1002/iid3.766}
}
Kostenlos starten →